Jiangsu gdk Biotechnology Co., Ltd. (688670.SS)
CNY 12.29
(-0.89%)
CNY 12.29
(-0.89%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 260.51 Million CNY | -29.03% |
| 2022 | 367.1 Million CNY | 25.24% |
| 2021 | 293.11 Million CNY | -45.26% |
| 2020 | 535.47 Million CNY | 5.89% |
| 2019 | 505.67 Million CNY | 26.19% |
| 2018 | 400.72 Million CNY | 11.5% |
| 2017 | 359.38 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 240.55 Million CNY | 30.36% |
| 2024 Q1 | 232.69 Million CNY | -10.68% |
| 2024 Q2 | 184.52 Million CNY | -20.7% |
| 2023 Q3 | 288.21 Million CNY | -17.75% |
| 2023 FY | 260.51 Million CNY | -29.03% |
| 2023 Q4 | 260.51 Million CNY | -9.61% |
| 2023 Q2 | 350.41 Million CNY | -8.06% |
| 2023 Q1 | 381.12 Million CNY | 3.82% |
| 2022 Q3 | 357.3 Million CNY | 43.97% |
| 2022 Q2 | 248.17 Million CNY | -10.28% |
| 2022 Q1 | 276.6 Million CNY | -5.63% |
| 2022 FY | 367.1 Million CNY | 25.24% |
| 2022 Q4 | 367.1 Million CNY | 2.74% |
| 2021 FY | 293.11 Million CNY | -45.26% |
| 2021 Q1 | 552.4 Million CNY | 3.16% |
| 2021 Q4 | 293.11 Million CNY | 12.92% |
| 2021 Q3 | 259.58 Million CNY | -53.7% |
| 2021 Q2 | 560.65 Million CNY | 1.49% |
| 2020 FY | 535.47 Million CNY | 5.89% |
| 2020 Q1 | - CNY | 0.0% |
| 2020 Q4 | 535.47 Million CNY | 0.0% |
| 2020 Q2 | 364.01 Million CNY | 0.0% |
| 2019 FY | 505.67 Million CNY | 26.19% |
| 2018 FY | 400.72 Million CNY | 11.5% |
| 2017 FY | 359.38 Million CNY | 0.0% |